University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Anthrax, otherwise known as the bacterium Bacillus anthracis, is a deadly serious infectious disease that kills without question if its toxins reach a host's cells. A new treatment developed by ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Zhanel, Winnipeg, MB Anthrax is a rare disease in the United Kingdom with ... procedures for medical and other staff in the UK. Treatment with ciprofloxacin for 60 days is recommended in adults ...

All signs of systemic reaction disappeared early in the course of treatment. Anthrax bacilli were repeatedly ... from the Research Fund for Infectious Diseases of the University of Pennsylvania ...

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

"Because the early symptoms of anthrax are non-specific and flu-like, the disease often isn't diagnosed until it's too late for current treatments to help. We need new approaches to treat this ...

“Because the early symptoms of anthrax are non-specific and flu-like, the disease often isn’t diagnosed until it’s too late for current treatments to help. We need new approaches to treat ...